Effects of Anthocyans on Cardiovascular and Sympathetic Function

This study has been completed.
Sponsor:
Collaborator:
MedPalett
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT00634387
First received: March 5, 2008
Last updated: July 3, 2011
Last verified: February 2010
  Purpose

Anthocyans modify cardiovascular and sympathetic function


Condition Intervention
Hypertension
Dietary Supplement: Anthocyans
Other: placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Anthocyans on Cardiovascular and Sympathetic Function

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Primary Outcome Measures:
  • Systolic bloodpressure and heartrate [ Designated as safety issue: No ]

Enrollment: 27
Study Start Date: March 2008
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: A
Anthocyans
Dietary Supplement: Anthocyans
Anthocyans
Dietary Supplement: Anthocyans
Placebo Comparator: B
no effective agent
Dietary Supplement: Anthocyans
Anthocyans
Other: placebo

  Eligibility

Ages Eligible for Study:   35 Years to 50 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ages 35 to 50 years old
  • Males
  • Hypertension
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00634387

Locations
Norway
Cardiovascular and Renal Research Center, Ulleval University Hospital
Oslo, Norway, 0407
Sponsors and Collaborators
Ullevaal University Hospital
MedPalett
  More Information

No publications provided

Responsible Party: Morten Rostrup MD PhD, Ullevaal University Hospital
ClinicalTrials.gov Identifier: NCT00634387     History of Changes
Other Study ID Numbers: AC2008
Study First Received: March 5, 2008
Last Updated: July 3, 2011
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Social Science Data Services
Norway: Directorate of Health

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 22, 2014